Skip to main content

Applied Genetic Technologies Corp

AGTCDelisted Dec 1, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001273636

Applied Genetic Technologies Corp was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Dec 1, 2022; 45 institutions reported holding it in 13F filings for Q3 2022, worth $3.34M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Applied Genetic Technologies Corp changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of AGTC: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders53147−5
Shares15.1M96.0K11.1M−3.92M (−26.1%)
Value$16.2M$103.0K$8.53M−$7.52M (−46.8%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Applied Genetic Technologies Corp at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to AGTC in Q2 2022
InstitutionSharesValue% of portfolio
HRT Financial LP69,536$53.0K0.00%
National Asset Management, Inc.20,000$16.0K0.00%
Tower Research Capital LLC (TRC)12,583$10.0K0.00%
UBS Group AG11,795$9.00K0.00%
Simplex Trading, LLC4,322$3.00K0.00%
Wagner Wealth Management, LLC165$00.00%
SOA Wealth Advisors, LLC.150$00.00%

Sold out (12)

Institutions that held Applied Genetic Technologies Corp at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of AGTC in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Ikarian Capital, LLC412,293$440.0K
Dimensional Fund Advisors LP203,000$217.0K
Ci Investments Inc.161,800$173.0K
Empery Asset Management, LP100,000$107.0K
Goldman Sachs Group Inc90,969$97.0K
Citadel Advisors LLC50,041$53.0K
Boothbay Fund Management, LLC38,953$42.0K
Jane Street Group, LLC12,936$14.0K
Aquatic Capital Management LLC1,700$2.00K
Citigroup Inc450$0
Royal Bank of Canada30$0
Federated Hermes, Inc.122–

Not filed for Q2 2022 yet (1)

Institutions that held Applied Genetic Technologies Corp at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AGTC in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Susquehanna Fundamental Investments, LLC96,020$103.0K